EP Patent

EP0846687A1 — Pyrazoles as human non-pancreatic secretory phospholipase A2 inhibitors

Assigned to Eli Lilly and Co · Expires 1998-06-10 · 28y expired

What this patent protects

A class of novel pyrazoles is disclosed together with the use of such compounds for inhibiting sPLA 2 mediated release of fatty acids for treatment of conditions such as septic shock.

USPTO Abstract

A class of novel pyrazoles is disclosed together with the use of such compounds for inhibiting sPLA 2 mediated release of fatty acids for treatment of conditions such as septic shock.

Drugs covered by this patent

Patent Metadata

Patent number: EP0846687A1
Jurisdiction: EP
Classification: —
Expires: 1998-06-10
Drug substance claim: No
Drug product claim: No
Assignee: Eli Lilly and Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.